Mercy BioAnalytics

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• Fyr Bio fyr.bioDirect competitorBoth use extracellular vesicle–based liquid biopsy platforms for oncology blood tests.
• Beken Bio beken.bioDirect competitorBoth develop blood-based liquid biopsy tests focused on ultra-early cancer detection.
• Epiliquid Holding, Inc epiliquid.comDirect competitorBoth build blood-based liquid biopsy tests for early cancer detection from molecular biomarkers.
• Cosomil cosomil.comDirect competitorBoth develop liquid biopsy diagnostics from blood for ultra-early cancer detection.
• OncoRevive oncorevive.comDirect competitorBoth offer liquid biopsy blood tests with AI and multiomics for early cancer detection.
• Freenome freenome.comPartial overlapBoth develop blood-based multiomics tests for early cancer detection in similar patient groups.
• GRAIL grail.comPartial overlapBoth offer blood-based multi-cancer early detection liquid biopsy tests.
• Delfi Diagnostics delfidiagnostics.comPartial overlapBoth provide AI-powered blood-based liquid biopsy tests for early cancer detection.